CVS CVS Health
Health Care · S&P 500
Next earnings: not announced yet
What 27 analyst firms say about CVS Health: their latest ratings, price targets and how far the stock is from them. How it works
Analyst window: Latest analyst report within last 1 year
Analyst view · last 1Y
23 rated views · 27 analyst/firm records · 27 firms
Radar score
Recent analyst activity · last 90 days
Our tracked history has 16 reports on CVS from 10 analyst firms in the last 90 days (27 firms in the past year).
Comparing each firm's latest target with its previous one: 1 raised its price target, 3 lowered it, 4 left it unchanged and 1 has its first observed target in the past year.
Ratings, latest available report against the previous one: 0 upgrades and 1 downgrade.
Latest observed target change: Barclays lowered its target from $108.00 (set 6 Aug 2026) to $107.00 on 5 Nov 2026.
Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.
| Firm | Analyst | Latest rating | Report date | Latest target (USD) |
|---|---|---|---|---|
| Argus | Steve Silver | Buy | 19 Aug 2026 | 114.00 USD |
| Baird | Michael Ha | ConflictConflicting reports · excluded | 6 Aug 2026 | 107.00 USD |
| Bank of America Securities | Allen Lutz | Buy | 22 Jun 2026 | 110.00 USD |
| Barclays | Andrew Mok | Buy | 6 Aug 2026 | 108.00 USD |
| Bernstein | Lance Wilkes | Buy | 9 Sep 2026 | 112.00 USD |
| BMO Capital Markets | Unnamed analyst | — | 9 Sep 2026 | 112.00 USD |
| Cantor Fitzgerald | Sarah James | Hold | 9 Oct 2026 | 110.00 USD · 11 Sep 2026 |
| DA Davidson | Unnamed analyst | Buy | 7 May 2026 | 100.00 USD |
| Deutsche Bank | Unnamed analyst | Buy | 7 May 2026 | 92.00 USD |
| Evercore ISI | Elizabeth Anderson | Buy | 7 Jul 2026 | 125.00 USD |
| Goldman Sachs | Scott Fidel | Buy | 14 May 2026 | 120.00 USD |
| HSBC | Daniela Bretthauer | Hold | 5 May 2026 | 103.00 USD |
| Jefferies | Brian G Tanquilut | Buy | 10 Jul 2026 | 120.00 USD |
| JPMorgan | Lisa Gill | Buy | 12 Aug 2026 | 118.00 USD |
| Leerink Partners | Michael Cherny | Buy | 12 Oct 2026 | 112.00 USD |
| Mizuho | Ann Hynes | Buy | 8 Jun 2026 | 115.00 USD |
| Morgan Stanley | Erin Wright | Buy | 4 Jun 2026 | 111.00 USD |
| Piper Sandler | Jessica Tassan | — | 9 Sep 2026 | 112.00 USD |
| Raymond James | Parker Snure | Buy | 5 Aug 2026 | — |
| RBC Capital Markets | Ben Hendrix | Buy | 9 Jul 2026 | 113.00 USD |
| TD Cowen | Charles Rhyee | Buy | 11 May 2026 | 110.00 USD |
| Truist | David MacDonald | Buy | 14 Jul 2026 | 118.00 USD |
| UBS | Kevin Caliendo | Buy | 22 Sep 2026 | Conflicting reports · excluded |
| Weiss Ratings | Unnamed analyst | — | 9 Oct 2026 | — |
| Wells Fargo | Stephen Baxter | Buy | 13 Jul 2026 | 123.00 USD |
| Wolfe Research | Justin Lake | Buy | 16 Jun 2026 | 110.00 USD |
| Data feed RESEARCH | Research Team | Hold | 25 Feb 2026 | 93.00 USD |
Partial coverage · checked 6 Nov (6 Nov 2026, 03:23 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.